List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 830 studies with search of:   Hungary
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Prospective Evaluation of Proteinuria and Renal Function in Non-Diabetic Patients With Progressive Renal Disease
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
2 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
3 Completed Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Conditions: Breast Cancer;   Metastases
Interventions: Drug: Ixabepilone + Capecitabine;   Drug: Capecitabine
4 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
5 Completed Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
Condition: NSCLC
Intervention: Drug: Gefitinib
6 Completed Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients
Condition: Parkinson Disease
Interventions: Drug: Pramipexol Extended Release;   Drug: Pramipexol Immediate Release;   Drug: Placebo
7 Recruiting Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
8 Completed BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046);   Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046);   Drug: Copaxone
9 Active, not recruiting Cetuximab Combined With Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
Condition: EGFR-Expressing Metastatic Colorectal Cancer
Interventions: Drug: Cetuximab, 5-Fluorouracil, Folinic acid, Irinotecan;   Drug: 5-Fluorouracil, Folinic acid, Irinotecan
10 Completed Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Roflumilast;   Drug: Placebo
11 Recruiting Study of Non-Small Cell Lung Cancer After Failure of at Least 1 Prior Platinum-Based Treatment
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Erlotinib (Tarceva®, OSI Pharmaceuticals, Inc, Hoffman-La Roche, Genentech, Inc);   Drug: Pralatrexate Injection
12 Recruiting E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes and Refractory to the Most Recent Chemotherapy
Condition: Metastatic Breast Cancer
Interventions: Drug: E7389;   Drug: Capecitabine
13 Recruiting A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Conditions: Tumor;   Pain
Interventions: Drug: CG5503 ER;   Drug: Placebo to match CG5503;   Drug: Morphine Sulphate CR;   Drug: Placebo to match Morphine Sulphate CR
14 Not yet recruiting The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Conditions: Atherosclerosis;   Cardiovascular Disease;   Coronary Heart Disease;   CV Risk
Interventions: Drug: Darapladib;   Drug: Placebo
15 Recruiting Study of LJP 394 in Lupus Patients With History of Renal Disease
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: abetimus sodium (LJP 394) and/or placebo solution;   Drug: abetimus sodium (LJP 394);   Drug: Phosphate-buffered saline
16 Completed Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
Conditions: Hypertension;   Hyperlipidemia
Intervention: Drug: Amlodipine/atorvastatin single pill
17 Terminated Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cisplatin;   Drug: Gemcitabine;   Drug: PF-3512676;   Drug: Cisplatin;   Drug: Gemcitabine + Cisplatin
18 Active, not recruiting A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Rasagiline Mesylate;   Drug: Rasagiline Mesylate
19 Active, not recruiting Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
Condition: Bacterial Pneumonia
Interventions: Drug: ceftaroline;   Drug: ceftriaxone
20 Recruiting Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Subjects With Symptoms of Overactive Bladder
Condition: Urinary Bladder, Overactive
Interventions: Drug: YM178;   Drug: Tolterodine 4 mg;   Drug: Placebo

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services